All Immunology articles – Page 46
-
NewsNew study to examine very rare adverse events linked to COVID-19 vaccines
A multimillion-dollar global initiative will study causes and risk factors, to ensure safer vaccines are ready for the next potential pandemic.
-
NewsVaccine speeds up the production of antibodies against Covid
A new vaccine uses preexisting immunity to a separate virus (the influenza virus) to help kickstart the process of making antibodies against SARS-CoV-2.
-
NewsResearch reveals why staph vaccine candidates keep failing - and how to fix the problem
Research from UC San Diego explains the clinical failure of dozens of candidate vaccines for one of the most common human infections; it also suggests a way to fix the problem.
-
NewsPriming vaccine tested by global project lays path to HIV vaccine
A global project is attemptng to discover a HIV vaccine based on germline targeting and that is practical for those in Low and Middle-Income Countries.
-
NewsStudy uncovers how gum disease aggravates COPD
A new study shows how periodontitis, an oral disease, activates immune cells associated with aggravated progression of COPD.
-
NewsHigher viral load during HIV infection can shape viral evolution
A new paper finds that HIV populations in people with higher viral loads also have higher rates of viral recombination.
-
NewsVaccine boosts innate immunity in people with dormant immune cells
Epigenetic cell states predict whether or not an individual profits from the “wake-up call” to the innate immune system that is provided by the BCG vaccine.
-
NewsGut bacteria combinations protect stem cell transplantation patients from dangerous immune reactions
Researchers have shown that graft versus host disease (GvHD) is less common when certain microbes are present in the gut. In the future, it may be possible to deliberately bring about this protective composition of the microbiome.
-
NewsResearchers decode the ‘cytokine storm’ in sepsis
The team found that three cytokine pairs were responsible for most of the body’s damaging response to sepsis.
-
NewsResearchers unmask an old foe’s tricks to thwart new diseases
Researchers are studying Yersinia pestis, the bacterium that causes bubonic and pneumonic plague, to better understand its ability to evade the immune system and apply that understanding to control other pathogens.
-
NewsConsuming fermented food natto suppresses arteriosclerosis
A study shows that the intake of natto alters the composition of intestinal microflora in a mouse model, regulating the production of cytokines and chemokines associated with arteriosclerosis.
-
NewsA high-fat diet could make you vulnerable to harmful microbes, including Covid
A new study demonstrates that high-fat diets negatively impact genes linked not only to obesity, colon cancer and irritable bowels, but also to the immune system, brain function, and potentially COVID-19 risk.
-
NewsB cell deficient patients gain protective T cell immunity after SARS-CoV-2 vaccination, infection
Researchers found that vaccinated B cell-deficient individuals had significantly reduced risk of moderate and severe disease in comparison to those who were not vaccinated, despite an absence of anti-spike antibody responses.
-
NewsResearchers ID opportunities to improve future HIV vaccine candidates
An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study.
-
NewsMultiple sclerosis: Possible basis for vaccine researched
Researchers have shown that the risk of MS is particularly high in people with a combination of certain host factors and variants of the Epstein-Barr virus (EBV).
-
NewsStudy reveals how the immune system fights to keep herpes at bay
A recent study, conducted using lab-engineered cells, unveils the precise maneuvers used by host and herpes simplex virus (HSV) in the fight for dominance of the cell.
-
NewsRisk of death reduces after COVID-19 vaccine but protection wanes after six months
The risk of death from COVID-19 decreases significantly after vaccination but this protection diminishes after six months, providing evidence for continued booster doses, a new study has found.
-
NewsMpox vaccine triggers equally strong immune response in smaller doses
Delivering the two-dose mpox vaccine in smaller than the usual FDA-approved doses produced a detectable immune response. This also occurred regardless of whether people were living with or without HIV.
-
NewsPatients can pause immune-suppressing medicines for COVID-19 booster vaccine
A major clinical trial shows that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
-
NewsT cells tackle new ‘Pirola’ SARS-CoV-2 variant
Scientists harness bioinformatics to predict how T cells may adapt to fighting the highly mutated Pirola variant.